Add to Favorites Newsroom RSS Share
fb-shareYale Cancer Center
New Haven, CT USA

Our News on Newswise

Smilow Cancer Hospital expert explains five things you need to know about Lung Cancer

Roy Herbst, M.D., Ph.D., chief of Medical Oncology at Smilow Cancer Hospital, has been researching lung cancer and treating patients with the disease for more than 25 years. He discusses the facts about lung cancer, ways to reduce your risk, and how...
4-Nov-2019 2:05 PM EST Add to Favorites

Newswise: BarbaraBurtnessMD.jpg

Yale Cancer Center study shows checkpoint inhibitor prolongs survival in patients with certain head and neck cancers

The checkpoint inhibitor pembrolizumab (Keytruda) offers patients with advanced head and neck cancers longer survival time, according to a new global study led by Yale Cancer Center (YCC).
30-Oct-2019 10:15 AM EDT Add to Favorites

Newswise: AlessandroSantin.jpg

Scientists build genomic research platform to help treat cervical cancer

Yale Cancer Center scientists have built a powerful genomic research platform to study cervical cancer, a disease that often is untreatable if it progresses after surgery or primary chemo-radiation treatment.
17-Oct-2019 4:35 PM EDT Add to Favorites

Newswise: RoyHerbstMDPhD.jpg

Researchers show genetic mutations in advanced lung cancer may predict improved outcomes

According to new findings by Yale Cancer Center scientists, higher levels of genetic mutations in a tumor biopsy are linked to improved clinical outcomes in patients using pembrolizumab (Keytruda) to treat non-small cell lung cancer (NSCLC).
27-Sep-2019 12:00 PM EDT Add to Favorites

Newswise: SuzanneEvansMDMPH.jpg

Yale Cancer Center Research Highlighted at ASTRO 2019

Yale Cancer Center (YCC) scientists presented research at the 61st annual American Society for Radiation Oncology (ASTRO) annual meeting in Chicago.
17-Sep-2019 6:00 PM EDT Add to Favorites

Adding Radiation After Immunotherapy Improves Survival Time for Patients with Advanced Lung Cancer

The results of a phase II clinical trial by Yale Cancer Center (YCC) researchers show adding high-dose radiation after immunotherapy stops working increases survival time for patients with metastatic non-small-cell lung cancer (NSCLC).
17-Sep-2019 3:55 PM EDT Add to Favorites

Newswise: RanjitBindraMDPhD.jpg

Yale Cancer Center finding offers hope for treatment of incurable Childhood Brain cancer

A team of investigators at Yale Cancer Center (YCC) have found a major chink in the armor of an incurable childhood brain cancer called Diffuse Intrinsic Pontine Gliomas (DIPG).
22-Aug-2019 11:10 AM EDT Add to Favorites

Newswise: DanPetrylakMD.jpg

Yale Cancer Center researchers demonstrate novel drug increased survival for patients with bladder cancer.

There are no approved treatment options for patients with advanced bladder cancer after standard chemotherapy and immune treatments, but the results of a phase II clinical trial led by Yale Cancer Center and Smilow Cancer Hospital researchers...
3-Jun-2019 7:30 AM EDT Add to Favorites

see all news

Our Experts on Newswise

Newswise: MichaelGirardiMDPhD.jpg

Five Ways to Lower Your Skin Cancer Risk

Experts at Yale Cancer Center say unless you take the right precautions, sun exposure (even if you don't get scorched) can damage your skin, causing wrinkles, age spots and even skin cancer.
22-Jun-2018 10:05 AM EDT

Yale Expert Discusses Treatment for Endometrial Cancer

Dr. Alesandro Santin Discusses Treatment for Endometrial Cancer
3-Apr-2018 3:55 PM EDT

Expert Speaks on Utilizing Information Technology to Address Oral Chemotherapy Challenges

Utilizing Information Technology to Address Oral Chemotherapy Challenges
26-Mar-2018 2:05 PM EDT

Newswise: prasanna.jpg

Yale Expert Available to Speak on Medical Marijuana for Children with Cancer

12-Mar-2018 3:05 PM EDT

Newswise: Capture.PNG

Overcoming Resistance to Immunotherapy

For some cancer patients, the road to remission and healing can have its share of speed bumps. That’s particularly true of patients with non-small cell lung cancer (NSCLC) who develop a secondary, or acquired, resistance to immunotherapy, which...
27-Oct-2017 11:50 AM EDT

Daniel P. Petrylak, MD, on Urothelial Carcinoma: Results of the RANGE Trial

6-Oct-2017 3:05 PM EDT

Newswise: LiepingChen.JPG

Yale Expert Wins Prestigious 2017 Warren Alpert Prize

6-Oct-2017 2:05 PM EDT

Newswise: CharlesFuchsMDMPHcasual.jpg

Backed by Yale Cancer Center Research, FDA Approves New Immunotherapy Drug for Stomach Cancer

22-Sep-2017 4:30 PM EDT

see all experts

Our YouTube Videos

Youtube feed not yet configured. Is this your Newswise member page? Contact to configure this module.


Yale Cancer Center combines a tradition of innovative cancer treatment and quality care for our patients. A National Cancer Institute (NCI) designated comprehensive cancer center for over 40 years, Yale Cancer Center is one of only 45 Centers in the nation.

Yale Cancer Center is a collaboration between nationally and internationally renowned scientists and physicians at Yale School of Medicine and Smilow Cancer Hospital at Yale-New Haven. This partnership enables the Center to provide the best approaches for prevention, detection, diagnosis, and treatment for cancer.


  • Anees Chagpar

    Associate Professor; Director, Assistant Director

    Breast Cancer, Yale Cancer Center, breast surgeon, hereditary breast and ovarian cancer syndrome breast cancer, Breast Neoplasms, Global affairs, Healthcare
  • Charles Fuchs

    Professor; Director; Physician-in-Chief

    Colorectal Cancer, Gastrointestinal Cancer, Yale Cancer Center, Cancer epidemiology, Cancer Prevention and Control
  • Roy Herbst

    Ensign Professor; Professor; Chief

    Lung Cancer, Nsclc, Clinical Trials For Cancer, Yale Cancer Center, Immunotherapy


Anne Doerr
Director of Media Relations


Renee Gaudette
Director of Marketing & Public Affairs


Scott Gettinger
Associate Professor of Medicine

Emily Montemerlo
Marketing Coordinator


Twitter twitter-icon

Chat now!